Gender Medicine in Russia: Goryacheva's Initiative or Market Redistribution?
Analysis of the bill on gender quotas in clinical trials. Find out who will benefit from the new rules in the $1.6 trillion market and how it will change the Russian pharmaceutical industry. Details inside.
